This year鈥檚 "Top Doctors" Connecticut Magazie issue includes 128 Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH) physicians, a 17 percent increase since last year.
Experts from Cedars-Sinai will present advances in research and clinical innovation at the annual Digestive Disease Week (DDW) scientific conference May 3-6 in San Diego.
The Society for Clinical Trials (SCT) is pleased to announce that the prestigious David Sackett Trial of the Year Award will be presented to 鈥淏linatumomab in Childhood Standard-Risk B-Cell Acute Lymphoblastic Leukemia.鈥�
Ulrich Steidl, M.D., Ph.D., professor and chair of cell biology at Albert Einstein College of Medicine and deputy director at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center, has been elected a member of the Association of American Physicians (AAP), a prestigious 140-year-old honorary society dedicated to advancing medical knowledge through basic and clinical science.
Indiana University School of Medicine scientists have developed a new imaging technique to study bone marrow in mouse models. This advancement could support future drug development and therapies for conditions involving bone marrow, including cancers, autoimmune diseases and musculoskeletal disorders.
JACKSONVILLE, Fl贸rida 鈥� Voc锚 tem se sentido cansado e ganhou peso. Pode ser apenas um sinal de que voc锚 est谩 envelhecendo, mas pode haver uma chance de que esses sintomas gerais sejam causados pelo鈥痟ipotiroidismo. O Dr. Victor Bernet,鈥痚ndocrinologista na Mayo Clinic, explica os fatores de risco e como essa condi莽茫o 茅 diagnosticada e tratada.
The Cedars-Sinai Board of Governors Regenerative Medicine Institute is marking its 15th anniversary by further expanding its commitment to research, development of cell-based human models and therapies, and education with three new leadership appointments and the creation of a master鈥檚 degree program.
A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.
The National Comprehensive Cancer Network (NCCN) is hosting an #NCCNPolicy Summit on how primary care and oncology care providers can coordinate better to improve treatment and outcomes.
Hackensack University Medical Center is Proud to Announce a Significant Advancement in Emergency Care for Our Communities
A new Cedars-Sinai study demonstrates how gut bacteria can influence the development of blood vessel inflammation in laboratory mice. The findings, if confirmed in humans, would open a potential route for treating Kawasaki disease, a mysterious childhood disorder characterized by vascular inflammation.
The test, called PROSTOX, is the first of its kind to use microRNAs to predict toxicity from cancer therapy. It could help prevent the burden of long-term complications by identifying patients most at risk before treatment even begins.
Collaborative research led by investigators at Dana-Farber/Boston Children's Cancer and Blood Disorders Center defines a novel approach to understanding how certain proteins called transcription factors determine which genetic programs will drive cell growth and maturation.
By analyzing DNA and proteins in the blood of people with and without acute spinal cord injuries (SCIs), researchers at the Johns Hopkins University School of Medicine have developed a novel blood test that has the potential to rapidly predict severity and likelihood of sensory and motor recovery within six months in a cost-effective manner.
South Africa鈥檚 2013 sodium reduction law is lowering blood pressure and improving health. A study by Wits & Harvard found a 10% drop in sodium intake, with stricter limits in processed foods. Even small reductions cut heart disease risk. Experts say more countries should follow suit. #PublicHealth
Atrial fibrillation (AFib) is the most common type of heart arrhythmia impacting more than 5 million people in the United States, a number that is anticipated to reach 12.1 million by 2030. The heart rhythm condition is characterized by fast and irregular heartbeats from the upper chambers of the heart. People with AFib are at increased risk of stroke, heart failure, dementia, and premature death.
A new discovery has shed new light on the crucial role of the CD47 protein in bone fracture healing. Scientists have identified CD47 as an essential regulator of mesenchymal progenitor cell (MSC) proliferation鈥攃ells critical for bone repair. Without CD47, bone healing was significantly delayed, with reduced callus formation and diminished bone volume in both normal and ischemic fracture models. These findings suggest that targeting CD47 could pave the way for novel therapeutic strategies to enhance fracture recovery, particularly in cases where blood supply is compromised.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 蜜桃传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right